Recurrence of hepatocellular carcinoma in chronic hepatitis C patients treated with direct acting antiviral agents (DAAs): a single center experience

(1) National Liver Institute,Cairo,Egypt

(2) National Liver Institute - Menoufia University,Menoifia,Egypt



This item was part of the Liver & Biliary II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019